Empress Therapeutics

Empress Therapeutics is a specialized company that focuses on the discovery and development of treatments that target specific cancer cells. Based on their proprietary platform, EmpressID, they are able to identify and exploit Empressome, a unique set of proteins found only in cancer cells. This unique approach enables them to create therapies that target cancer cells without harming healthy ones, potentially improving the effectiveness and safety of cancer treatment.

In addition to this, Empress Therapeutics is also dedicated to collaborations with other companies and research institutions to speed up the development of their cancer therapies. They leverage their unique technology to identify new targets for cancer drugs, allowing them to rapidly advance their research and development efforts. The ultimate goal of Empress Therapeutics is to provide a new line of defense in the battle against cancer, offering hope for patients around the world.